SCPHARMACEUTICALS INC (SCPH) Stock Earnings & Estimates
USA - NASDAQ:SCPH - US8106481059 - Common Stock
5.62 USD
-0.01 (-0.18%)
5.6106 USD
-0.01 (-0.17%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13.593M | 36.332M 167.28% | 74.226M 104.30% | 130.68M 76.06% | 189.98M 45.38% | 246.51M 29.76% | 301.49M 22.30% | 364.83M 21.01% | 477.91M 31.00% | 543.89M 13.81% | ||
| EBITDA YoY % growth | -36.12M -40.05% | -54.77M -51.63% | -64.628M -18.00% | -48.552M 24.87% | -9.996M 79.41% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -36.16M -40.05% | -55.396M -53.20% | -64.776M -16.93% | -55.023M 15.06% | -5.469M 90.06% | 41.946M 866.91% | 86.926M 107.23% | 127.1M 46.22% | 177.66M 39.78% | 278.81M 56.93% | 331.72M 18.98% | |
| Operating Margin | N/A | -407.53% | -178.29% | -74.13% | -4.19% | 22.08% | 35.26% | 42.16% | 48.70% | 58.34% | 60.99% | |
| EPS YoY % growth | -1.30 -26.21% | -1.42 -9.23% | -1.90 -33.80% | -1.09 42.69% | -0.23 79.02% | 0.64 379.02% | 1.29 102.67% | 1.85 43.42% | 2.61 41.10% | 4.19 60.34% | 4.69 11.92% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.24 68.38% | -0.17 50.46% | -0.11 71.05% | -0.11 67.00% | -0.06 74.19% | -0.04 76.47% |
| Revenue Q2Q % growth | 20.051M 99.99% | 26.102M 114.83% | 26.928M 129.14% | 28.764M 79.32% | 30.447M 51.85% | 34.425M 31.89% |
| EBITDA Q2Q % growth | -10.506M 41.82% | -7.65M 52.76% | -6.222M 64.84% | -4.488M 68.32% | -1.122M 89.32% | 102K 101.33% |
| EBIT Q2Q % growth | -12.232M 32.59% | -8.62M 47.26% | -6.732M 62.09% | -4.998M 65.03% | -1.836M 84.99% | 1.632M 118.93% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.34 22.73% | -0.30 | -0.04 | -11.86% |
| Q1 2025 Q2Q % growth | -0.37 -2.78% | -0.30 | -0.07 | -21.73% |
| Q4 2024 Q2Q % growth | -0.35 | -0.39 | 0.04 | 9.30% |
| Q3 2024 Q2Q % growth | -0.75 -82.93% | -0.30 | -0.45 | -147.99% |
| Q2 2024 Q2Q % growth | -0.44 -22.22% | -0.42 | -0.02 | -4.20% |
| Q1 2024 Q2Q % growth | -0.36 -20.00% | -0.45 | 0.09 | 19.24% |
| Q4 2023 Q2Q % growth | -0.35 -16.67% | -0.43 | 0.08 | 18.07% |
| Q3 2023 Q2Q % growth | -0.41 -10.81% | -0.37 | -0.04 | -10.18% |
| Q2 2023 Q2Q % growth | -0.36 -2.86% | -0.38 | 0.02 | 5.23% |
| Q1 2023 Q2Q % growth | -0.30 -7.14% | -0.37 | 0.07 | 19.42% |
| Q4 2022 Q2Q % growth | -0.30 -11.11% | -0.39 | 0.09 | 24.00% |
| Q3 2022 Q2Q % growth | -0.37 -54.17% | -0.39 | 0.02 | 5.16% |
| Q2 2022 Q2Q % growth | -0.35 -34.62% | -0.31 | -0.04 | -13.12% |
| Q1 2022 Q2Q % growth | -0.28 -7.69% | -0.32 | 0.04 | 11.45% |
| Q4 2021 Q2Q % growth | -0.27 3.57% | -0.35 | 0.08 | 22.90% |
| Q3 2021 Q2Q % growth | -0.24 27.27% | -0.32 | 0.08 | 24.91% |
| Q2 2021 Q2Q % growth | -0.26 27.78% | -0.31 | 0.05 | 15.03% |
| Q1 2021 Q2Q % growth | -0.26 25.71% | -0.31 | 0.05 | 15.03% |
| Q4 2020 Q2Q % growth | -0.28 51.72% | -0.37 | 0.09 | 24.45% |
| Q3 2020 Q2Q % growth | -0.33 | -0.39 | 0.06 | 15.42% |
| Q2 2020 Q2Q % growth | -0.36 7.69% | -0.43 | 0.07 | 16.46% |
| Q1 2020 Q2Q % growth | -0.35 25.53% | -0.55 | 0.20 | 36.16% |
| Q4 2019 Q2Q % growth | -0.58 | -0.54 | -0.04 | -8.31% |
| Q3 2019 Q2Q % growth | -0.33 | -0.46 | 0.13 | 27.70% |
| Q2 2019 Q2Q % growth | -0.39 | -0.50 | 0.11 | 21.43% |
| Q1 2019 Q2Q % growth | -0.47 | -0.53 | 0.06 | 10.82% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 16.041M 99.17% | 15.722M | 319K | 2.03% |
| Q1 2025 Q2Q % growth | 11.752M 92.59% | 11.861M | -109K | -0.92% |
| Q4 2024 Q2Q % growth | 12.15M 99.31% | 12.326M | -176K | -1.43% |
| Q3 2024 Q2Q % growth | 10.026M 164.12% | 11.017M | -991K | -9.00% |
| Q2 2024 Q2Q % growth | 8.054M 391.70% | 8.129M | -75K | -0.92% |
| Q1 2024 Q2Q % growth | 6.102M 195.78% | 6.097M | 5K | 0.08% |
| Q4 2023 Q2Q % growth | 6.096M | 5.636M | 460K | 8.16% |
| Q3 2023 Q2Q % growth | 3.796M | 3.459M | 337K | 9.74% |
| Q2 2023 Q2Q % growth | 1.638M | 1.65M | -12K | -0.73% |
| Q1 2023 Q2Q % growth | 2.063M | 1.394M | 669K | 47.99% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.64% | 4.71% | -2.15% | -4.98% |
| Revenue | -4.6% | -4.6% | -2.23% | -2.23% |